Normalization of Patient-Identified Plasma Biomarkers in SMNΔ7 Mice following Postnatal SMN Restoration.
Spinal muscular atrophy (SMA) is an autosomal recessive motor neuron disorder. SMA is caused by homozygous loss of the SMN1 gene and retention of the SMN2 gene resulting in reduced levels of full length SMN protein that are insufficient for motor neuron function. Various treatments that restore leve...
Main Authors: | W David Arnold, Sandra Duque, Chitra C Iyer, Phillip Zaworski, Vicki L McGovern, Shannon J Taylor, Katharine M von Herrmann, Dione T Kobayashi, Karen S Chen, Stephen J Kolb, Sergey V Paushkin, Arthur H M Burghes |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5132001?pdf=render |
Similar Items
-
The neuromuscular impact of symptomatic SMN restoration in a mouse model of spinal muscular atrophy
by: W. Arnold, et al.
Published: (2016-03-01) -
Dual SMN inducing therapies can rescue survival and motor unit function in symptomatic ∆7SMA mice
by: Kaitlyn M. Kray, et al.
Published: (2021-11-01) -
Abnormal motor phenotype in the SMNΔ7 mouse model of spinal muscular atrophy
by: Matthew E.R. Butchbach, et al.
Published: (2007-08-01) -
Lysine-Less Variants of Spinal Muscular Atrophy SMN and SMNΔ7 Proteins Are Degraded by the Proteasome Pathway
by: Raúl Sánchez-Lanzas, et al.
Published: (2017-12-01) -
SMN Protein Can Be Reliably Measured in Whole Blood with an Electrochemiluminescence (ECL) Immunoassay: Implications for Clinical Trials.
by: Phillip Zaworski, et al.
Published: (2016-01-01)